Market Overview

Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of MEDNAX, Inc. Investors


Law Offices of Howard G. Smith announces that a class action lawsuit has
been filed on behalf of investors that purchased MEDNAX, Inc. ("Mednax"
or the "Company") (NYSE: MD)
securities between February 4, 2016 to July 27, 2017, inclusive
(the "Class Period"). Mednax investors have until September 10, 2018 to
file a lead plaintiff motion.

Investors that suffered losses on their Mednax investments are
encouraged to contact the Law Offices of Howard G. Smith to discuss
their legal rights in this class action at 888-638-4847 or by email to

On April 20, 2017, Mednax announced poor financial results for the first
quarter of 2017, including missed earnings. Mednax also reported that
"[s]ame-unit revenue from net reimbursement-related factors is expected
to decline by 0.6 percent for the first quarter of 2017, compared to the
first quarter of 2016, driven by a 90 basis point payor mix shift to
government payors that impacted same-unit pricing negatively by 150
basis points." On this news, Mednax's share price fell $5.39, or 8.1%,
to close at $61.30 per share on April 20, 2017.

Then, on July 28, 2017, during its second quarter earnings call, Mednax
announced that the Company had failed to complete acquisitions of
anesthesiologist practices during the quarter and that any future
anesthesiologist acquisitions were unlikely, citing the "challenging"
payor mix combined with "continued . . . growth in compensation expense
for nurse anesthetists." On this news, Mednax's share price fell $8.76
or 15.5%, to close at $47.73 per share on July 28, 2017, thereby further
injuring investors.

The Complaint alleges that throughout the Class Period, Defendants made
materially false and/or misleading statements and/or failed to disclose
that: (1) the Company's business model depended on growth from the
acquisition of new practice groups, primarily in anesthesiology; and
that (2) Mednax's business model is not sustainable and its growth was
based upon suppressing physician compensation and enforcing non-compete
agreements to deter physician defections.

If you purchased shares of Mednax during the Class Period, have
information or would like to learn more about these claims, or have any
questions concerning this announcement or your rights or interests with
respect to these matters, please contact Howard G. Smith, Esquire, of
Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem,
Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888)
638-4847, or by email to,
or visit our website at

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.

View Comments and Join the Discussion!